{
    "ticker": "ONCSQ",
    "name": "OncoSec Medical Incorporated",
    "description": "OncoSec Medical Incorporated is a biotechnology company focused on developing innovative immunotherapy treatments for cancer. Founded in 2011 and based in San Diego, California, OncoSec aims to harness the body\u2019s immune system to fight cancer, utilizing its proprietary technology platform known as ImmunoPulse. This platform administers a unique combination of electroporation with intratumoral delivery of therapeutic agents, including DNA-based therapies, to stimulate a robust immune response against tumors. OncoSec's flagship product, ONCOS-102, targets various types of solid tumors and is currently in clinical development. The company is dedicated to advancing the field of cancer treatment and has ongoing clinical trials aimed at assessing the safety and efficacy of its therapies in combination with checkpoint inhibitors. With a strong emphasis on scientific research and collaboration with leading clinical centers, OncoSec strives to improve the outcomes for patients suffering from cancer and is committed to bringing new therapies to market that can transform cancer care.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2011",
    "website": "https://www.oncosec.com",
    "ceo": "Daniel O'Connor",
    "social_media": {
        "twitter": "https://twitter.com/OncoSec",
        "linkedin": "https://www.linkedin.com/company/oncosec-medical-incorporated/"
    },
    "investor_relations": "https://www.oncosec.com/investors",
    "key_executives": [
        {
            "name": "Daniel O'Connor",
            "position": "CEO"
        },
        {
            "name": "Robert S. P. K. E. T. L. H. P. K. H. T. H. P. K. H. T. H. P. K. H. T. H. P. K. H. T. H. P. K.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Immunotherapy",
            "products": [
                "ONCOS-102"
            ]
        }
    ],
    "seo": {
        "meta_title": "OncoSec Medical | Innovative Cancer Immunotherapy",
        "meta_description": "OncoSec Medical is a biotechnology company focused on developing immunotherapy treatments for cancer using its proprietary ImmunoPulse technology.",
        "keywords": [
            "OncoSec",
            "Immunotherapy",
            "Cancer Treatment",
            "Biotechnology",
            "ONCOS-102"
        ]
    },
    "faq": [
        {
            "question": "What is OncoSec Medical known for?",
            "answer": "OncoSec Medical is known for developing innovative immunotherapy treatments for cancer using electroporation technology."
        },
        {
            "question": "Who is the CEO of OncoSec Medical?",
            "answer": "Daniel O'Connor is the CEO of OncoSec Medical Incorporated."
        },
        {
            "question": "Where is OncoSec headquartered?",
            "answer": "OncoSec is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is ONCOS-102?",
            "answer": "ONCOS-102 is OncoSec's lead immunotherapy product targeting solid tumors."
        },
        {
            "question": "When was OncoSec founded?",
            "answer": "OncoSec was founded in 2011."
        }
    ],
    "competitors": [
        "NK",
        "CLVS",
        "TGTX"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BIIB",
        "REGN"
    ]
}